Clinical Trial Update: Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

A randomized phase 2 trial evaluating neoadjuvant chemotherapy customized by BRCA1- and HER2-negative breast cancer has completed. The update indicates the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED